OpenAlex
PricingAboutJobs
Log inGet started
Work

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions

HTML

Year: 2004
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2003-10-3729
Authors: Gerard Lozanski, Nyla A. Heerema, Ian W. Flinn, Lisa Smith, Jennifer Harbison, Jennifer Webb, Mollie Moran, Margaret Lucas, Thomas Lin, Marcy L. Hackbarth, John H. Proffitt, David Lucas, Michael R. Grever, John C. Byrd
Institutions: Johns Hopkins University, The Ohio State University
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: Innate Immunity: Elucidation and Modulation for Cancer Therapy, G712716689
OpenAlex ID: W2159880472
FWCI: 23.03
Cites: 22
Cited by: 405
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms